Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows <100-fold selectivity for FAAH-1 than FAAH-2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 67.00 | |
25 mg | In stock | $ 143.00 | |
50 mg | In stock | $ 228.00 | |
100 mg | In stock | $ 368.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2. |
Targets&IC50 | FAAH (rat):10 nM, FAAH (human):12 nM |
Synonyms | JNJ1661010, Takeda-25, JNJ 1661010 |
Molecular Weight | 365.45 |
Formula | C19H19N5OS |
CAS No. | 681136-29-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 3.7 mg/mL (10 mM)
DMSO: 36.6 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-1661010 681136-29-8 Metabolism Neuroscience FAAH broad-spectrum acid inhibit hydrolase barrier JNJ1661010 Takeda25 Fatty acid amide hydrolase amide Takeda 25 blood-brain Inhibitor analgesics Takeda-25 Fatty JNJ 1661010 inhibitor